RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Pursuing a Gut Feeling: Exploring Immune Cell Trafficking Inhibitors to Treat IBD

by David Rubin | March 2, 2021 | In the Press | 0 Comments

Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.

Hospital-stay duration after IBD surgery not linked to sleep, activity

by dtrubin | December 16, 2019 | biosensor, In the Press | 0 Comments

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale

by David Rubin | January 18, 2022 | In the Press | 0 Comments

Click here to listen to the full interview.

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

by dtrubin | March 26, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

by David Rubin | April 18, 2021 | Coronavirus, Rubin's Reflections | 0 Comments

Long-Duration Vancomycin Linked to Lower Rates of C. diff Recurrence in IBD

by dtrubin | December 6, 2019 | In the Press | 0 Comments

Pritzker medical student Donald Lei's manuscript was accepted to the American Journal of Gastroenterology. Reuters Health Information reported on the study with comments by Dr. Rubin. "Our study did in fact demonstrate significantly reduced rates of recurrence...

IBD Drive Time: Dr. David Rubin, MD, on Ozanimod in Ulcerative Colitis

by David Rubin | August 6, 2021 | In the Press | 0 Comments

Click here to listen to Dr. Rubin speak with colleagues and IBD Drive Time hosts Raymond Cross, MD and Millie Long, MD on using newly-approved ozanimod in treating ulcerative colitis.

Lee Matricaria’s Story

by David Rubin | February 12, 2021 | In the Press | 0 Comments

How to identify, manage patients with high-risk ulcerative colitis

by dtrubin | November 5, 2019 | In the Press, Presentations, UC | 0 Comments

Dr. Rubin discusses his presentation at ACG 2019 in San Antonio on identifying and managing patients with high-risk ulcerative colitis with Healio Gastroenterology. “The importance of knowing who is high risk has to do with your choices of treatment and your...

How should you treat active IBD during the SARS-CoV-2 pandemic?

by dtrubin | March 21, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Colleagues, A question that has come up recently is how we should approach treating active IBD during the SARS-CoV-2 pandemic. Here are my...